Free Trial

Baird Financial Group Inc. Sells 20,553 Shares of Celestica, Inc. $CLS

Celestica logo with Computer and Technology background

Key Points

  • Baird Financial Group Inc. reduced its stake in Celestica, Inc. by 34.3%, selling 20,553 shares and retaining 39,316 shares, worth approximately $3.1 million.
  • Celestica reported earnings of $1.39 per share, exceeding analysts' expectations, and a revenue of $2.89 billion, marking a 21% year-over-year increase.
  • Multiple research analysts raised their price targets on Celestica, with JPMorgan setting a new target of $225.00 and Canaccord Genuity raising theirs to $240.00.
  • Interested in Celestica? Here are five stocks we like better.

Baird Financial Group Inc. decreased its position in Celestica, Inc. (NYSE:CLS - Free Report) TSE: CLS by 34.3% during the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 39,316 shares of the technology company's stock after selling 20,553 shares during the quarter. Baird Financial Group Inc.'s holdings in Celestica were worth $3,098,000 at the end of the most recent reporting period.

Several other large investors have also made changes to their positions in CLS. Rothschild Investment LLC bought a new stake in shares of Celestica in the 1st quarter worth about $26,000. ORG Partners LLC bought a new stake in shares of Celestica in the 1st quarter worth about $29,000. Center for Financial Planning Inc. bought a new stake in shares of Celestica in the 1st quarter worth about $30,000. Farther Finance Advisors LLC grew its holdings in shares of Celestica by 1,516.7% in the 1st quarter. Farther Finance Advisors LLC now owns 679 shares of the technology company's stock worth $54,000 after purchasing an additional 637 shares during the last quarter. Finally, Gordian Capital Singapore Pte Ltd grew its holdings in shares of Celestica by 8,910.0% in the 1st quarter. Gordian Capital Singapore Pte Ltd now owns 901 shares of the technology company's stock worth $71,000 after purchasing an additional 891 shares during the last quarter. Institutional investors own 67.38% of the company's stock.

Celestica Trading Up 0.7%

Celestica stock traded up $1.66 during mid-day trading on Monday, hitting $244.34. The stock had a trading volume of 4,337,393 shares, compared to its average volume of 3,046,431. The stock has a 50-day simple moving average of $185.74 and a two-hundred day simple moving average of $131.36. The stock has a market capitalization of $28.11 billion, a PE ratio of 52.89 and a beta of 1.89. Celestica, Inc. has a 12 month low of $41.74 and a 12 month high of $257.40. The company has a current ratio of 1.44, a quick ratio of 0.86 and a debt-to-equity ratio of 0.48.

Celestica (NYSE:CLS - Get Free Report) TSE: CLS last posted its quarterly earnings results on Monday, July 28th. The technology company reported $1.39 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.23 by $0.16. The business had revenue of $2.89 billion for the quarter, compared to analysts' expectations of $2.65 billion. Celestica had a return on equity of 28.23% and a net margin of 5.11%.The firm's quarterly revenue was up 21.0% compared to the same quarter last year. During the same quarter last year, the business earned $0.91 earnings per share. Celestica has set its Q3 2025 guidance at 1.370-1.530 EPS. FY 2025 guidance at 5.500-5.500 EPS. As a group, sell-side analysts forecast that Celestica, Inc. will post 4.35 EPS for the current year.

Analyst Ratings Changes

Several research firms have recently weighed in on CLS. BMO Capital Markets reaffirmed an "outperform" rating and issued a $130.00 target price (up previously from $118.00) on shares of Celestica in a report on Thursday, May 22nd. Citigroup lifted their price target on Celestica from $172.00 to $212.00 and gave the company a "neutral" rating in a report on Wednesday, July 30th. UBS Group reaffirmed a "neutral" rating and issued a $208.00 price target (up from $101.00) on shares of Celestica in a report on Wednesday, July 30th. BNP Paribas raised Celestica to a "strong-buy" rating in a report on Wednesday, June 11th. Finally, Wall Street Zen raised Celestica from a "hold" rating to a "buy" rating in a report on Saturday, August 2nd. Two analysts have rated the stock with a Strong Buy rating, ten have assigned a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat.com, the stock presently has an average rating of "Buy" and a consensus price target of $174.75.

Check Out Our Latest Stock Analysis on Celestica

About Celestica

(Free Report)

Celestica Inc provides supply chain solutions in North America, Europe, and Asia. It operates through two segments: Advanced Technology Solutions, and Connectivity & Cloud Solutions. The company offers a range of product manufacturing and related supply chain services, including design and development, new product introduction, engineering services, component sourcing, electronics manufacturing and assembly, testing, complex mechanical assembly, systems integration, precision machining, order fulfillment, logistics, asset management, product licensing, and after-market repair and return services.

See Also

Institutional Ownership by Quarter for Celestica (NYSE:CLS)

Should You Invest $1,000 in Celestica Right Now?

Before you consider Celestica, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Celestica wasn't on the list.

While Celestica currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.